United States · Markets & Finance · Morningstar

Fall Clinical 2026: Galderma Presents New Three-Year Nemluvio® Data Showing Deep and Lasting Skin Lesion and Itch Responses in Patients With Atopic Dermatitis Aged 12 and Older

Published by Morningstar · United States 11 h ago

Galderma Presents New Three-Year Nemluvio ® Data Showing Deep and Lasting Skin Lesion and Itch Responses in Patients With Atopic Dermatitis Aged 12 and Older.

Read the full article on Morningstar Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.morningstar.com)

Also worth reading

Cointelegraph

Crypto investment firm Deus X Capital shuts down as backers pursue separate strategies

CNBC

The Indian billionaire investing in Trump's refinery project is also buying more Venezuelan crude

Fortune

Fall Clinical 2026: Galderma Presents New Three-Year Nemluvio® Data Showing Deep and Lasting Skin Lesion and Itch Responses in Patients With Atopic Dermatitis Aged 12 and Older

Share

Also worth reading

Standard Chartered plans institutional crypto custody in Singapore

Michael Burry says Microsoft uses spending metrics ‘as a lever’ to get its way

Big Oil Begins Shutting In Gulf of Mexico Production

Crypto investment firm Deus X Capital shuts down as backers pursue separate strategies

The Indian billionaire investing in Trump's refinery project is also buying more Venezuelan crude

Trump keeps changing who gets his $5,000 dividend, and only 21% of voters believe he’ll actually pay it